Fennec Pharmaceuticals (FENC) Amortization - Deferred Charges (2019 - 2025)
Historic Amortization - Deferred Charges for Fennec Pharmaceuticals (FENC) over the last 7 years, with Q3 2025 value amounting to $12000.0.
- Fennec Pharmaceuticals' Amortization - Deferred Charges fell 4285.71% to $12000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $63000.0, marking a year-over-year decrease of 5298.51%. This contributed to the annual value of $89000.0 for FY2024, which is 6898.95% down from last year.
- Per Fennec Pharmaceuticals' latest filing, its Amortization - Deferred Charges stood at $12000.0 for Q3 2025, which was down 4285.71% from $13000.0 recorded in Q2 2025.
- Fennec Pharmaceuticals' 5-year Amortization - Deferred Charges high stood at $141000.0 for Q4 2022, and its period low was $7000.0 during Q1 2022.
- Over the past 5 years, Fennec Pharmaceuticals' median Amortization - Deferred Charges value was $22000.0 (recorded in 2024), while the average stood at $40125.0.
- Its Amortization - Deferred Charges has fluctuated over the past 5 years, first crashed by 9774.65% in 2021, then surged by 92857.14% in 2023.
- Over the past 5 years, Fennec Pharmaceuticals' Amortization - Deferred Charges (Quarter) stood at $8000.0 in 2021, then skyrocketed by 1662.5% to $141000.0 in 2022, then plummeted by 50.35% to $70000.0 in 2023, then plummeted by 64.29% to $25000.0 in 2024, then crashed by 52.0% to $12000.0 in 2025.
- Its last three reported values are $12000.0 in Q3 2025, $13000.0 for Q2 2025, and $13000.0 during Q1 2025.